Solid Biosciences Inc. Other Current Liabilities
Solid Biosciences Inc. (SLDB) had Other Current Liabilities of $92.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-05-15
- 2024-03-31: Other Liabilities, Current $92.00K.
- 2023-12-31: Other Liabilities, Current $24.00K.
- 2023-09-30: Other Liabilities, Current $162.00K.
- 2023-06-30: Other Liabilities, Current $117.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-03-31 | $92.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $24.00K 10-Q · filed 2024-05-15 |
| 2023-09-30 | $162.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $117.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $55.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $14.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $85.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $23.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $150.00K 10-Q · filed 2022-04-27 |
| 2021-12-31 | $35.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $73.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $61.00K 10-Q · filed 2021-08-16 |
| 2019-12-31 | $52.00K 10-K · filed 2021-03-15 |
| 2019-09-30 | $221.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $278.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $355.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $382.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $233.00K 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |